Ranking by Regions
United States
Canada
Mexico
Brazil
Chile
Germany
United Kingdom
France
Spain
Netherlands
Sweden
Italy
Switzerland
Poland
Finland
China
Japan
South Korea
Hong Kong
Singapore
Indonesia
India
Malaysia
Taiwan
Thailand
Australia
New Zealand
Israel
Saudi Arabia
Turkey
Russia
South AfricaRanking by categories
As of January 22, 2025, Anixa Biosciences (ANIX) has a market cap of $95.786 million USD. According to our data, Anixa Biosciences is ranked No.7722 in global market value.
| Year | Market Cap | %Change |
|---|---|---|
| Jan 22, 2025 | $95.79 M |
28.23%
|
| Dec 31, 2024 | $74.70 M |
-40.21%
|
| Dec 29, 2023 | $0.12 B |
-8.71%
|
| Dec 30, 2022 | $0.14 B |
43.10%
|
| Dec 31, 2021 | $95.62 M |
-3.26%
|
| Dec 31, 2020 | $98.84 M |
-6.40%
|
| Dec 31, 2019 | $0.11 B |
-16.75%
|
| Dec 31, 2018 | $0.13 B |
66.95%
|
| Dec 29, 2017 | $75.98 M |
-56.30%
|
| Dec 30, 2016 | $0.17 B |
79.40%
|
| Dec 31, 2015 | $96.91 M |
9.45%
|
| Dec 31, 2014 | $88.54 M |
-42.11%
|
| Dec 31, 2013 | $0.15 B |
5.56%
|
| Dec 31, 2012 | $0.14 B |
63.64%
|
| Dec 30, 2011 | $88.54 M |
-47.62%
|
| Dec 31, 2010 | $0.17 B |
-67.19%
|
| Dec 31, 2009 | $0.52 B |
48.84%
|
| Dec 31, 2008 | $0.35 B |
-70.34%
|
| Dec 31, 2007 | $1.17 B |
49.48%
|
| Dec 29, 2006 | $0.78 B |
22.78%
|
| Dec 30, 2005 | $0.64 B |
-7.06%
|
| Dec 31, 2004 | $0.68 B |
84.78%
|
| Dec 31, 2003 | $0.37 B |
142.11%
|
| Dec 31, 2002 | $0.15 B |
-55.81%
|
| Dec 31, 2001 | $0.35 B |
-37.45%
|
| Dec 29, 2000 | $0.55 B |
-15.38%
|
| Dec 31, 1999 | $0.65 B |
-36.59%
|
| Dec 31, 1998 | $1.03 B |
-63.39%
|
| Dec 31, 1997 | $2.82 B |
-29.11%
|
| Dec 31, 1996 | $3.97 B |
2.60%
|
| Dec 29, 1995 | $3.87 B |
52.48%
|
| Dec 30, 1994 | $2.54 B |
-51.44%
|
| Dec 31, 1993 | $5.23 B |
6.12%
|
| Dec 31, 1992 | $4.93 B |
2.08%
|
| Dec 31, 1991 | $4.83 B |
115.73%
|
| Dec 31, 1990 | $2.24 B |
-19.09%
|
| Dec 29, 1989 | $2.77 B |
-4.35%
|
| Dec 30, 1988 | $2.89 B |
79.69%
|
| Dec 31, 1987 | $1.61 B |
-13.04%
|
| Dec 31, 1986 | $1.85 B |
-23.33%
|
| Dec 31, 1985 | $2.41 B |
74.76%
|
| Dec 31, 1984 | $1.38 B |
-17.60%
|
| Dec 30, 1983 | $1.68 B |
100%
|
| Name | Market Cap | Market cap difference | Regions |
|---|---|---|---|
 Gilead Sciences
GILD
|
$115.95 B |
0.002 M
|
USA
|
 Amgen
AMGN
|
$146.98 B |
0.004 M
|
USA
|
 Biogen
BIIB
|
$20.80 B |
0.000 M
|
USA
|
 Regeneron Pharmaceuticals
REGN
|
$74.73 B |
1.236 B
|
USA
|
 Moderna
MRNA
|
$14.82 B |
-0.000 M
|
USA
|
 BioNTech
BNTX
|
$27.61 B |
0.000 M
|
Germany
|
 Novavax
NVAX
|
$1.41 B |
-0.000 M
|
USA
|
 Inovio Pharmaceuticals
INO
|
$81.23 M |
0.000 M
|
USA
|
 bluebird bio
BLUE
|
$76.22 M |
0.000 M
|
USA
|
 CRISPR Therapeutics
CRSP
|
$3.77 B |
-0.000 M
|
Switzerland
|
 Editas Medicine
EDIT
|
$0.11 B |
-0.000 M
|
USA
|
 Intellia Therapeutics
NTLA
|
$1.12 B |
0.000 M
|
USA
|
 Sangamo Therapeutics
SGMO
|
$0.24 B |
-0.000 M
|
USA
|
 Fate Therapeutics
FATE
|
$0.15 B |
0.000 M
|
USA
|
| Market Cap | = | ANIX Stock Price | * | ANIX Shares Outstanding |
| = | $2.97 | * | 32.20 M | |
| = | $95.79 M |